Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 202638

1.

Hepatitis E.

Waqar S, Koirala J.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 1.

2.

Fever of Unknown Origin (FUO).

Brown I, Finnigan NA.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 15.

3.

Prevalence and predictive value of high-positive rheumatoid factor and anti-citrullinated protein antibody levels in nonarthritic patients with chronic hepatitis C infection.

Lin KM, Chen WM, Tung SY, Wei KL, Shen CH, Chang TS, Chang PJ.

Int J Rheum Dis. 2018 Oct 18. doi: 10.1111/1756-185X.13388. [Epub ahead of print]

PMID:
30338656
4.

Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.

Watanabe T, Fukae J, Fukaya S, Sawamukai N, Isobe M, Matsuhashi M, Shimizu M, Akikawa K, Tanimura K, Atsumi T, Koike T.

Int J Rheum Dis. 2018 Oct 18. doi: 10.1111/1756-185X.13401. [Epub ahead of print]

PMID:
30338649
5.

Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion.

von Olshausen G, Quasdorff M, Bester R, Arzberger S, Ko C, van de Klundert M, Zhang K, Odenthal M, Ringelhan M, Niessen CM, Protzer U.

Oncotarget. 2018 Sep 21;9(74):33947-33960. doi: 10.18632/oncotarget.26103. eCollection 2018 Sep 21.

PMID:
30338037
6.

Knowledge and Awareness towards Occupational Hazards and Preventive Measures among Students and Dentists in Jazan Dental College, Saudi Arabia.

Al-Aslami RA, Elshamy FMM, Maamar EM, Shannaq AY, Dallak AE, Alroduni AA.

Open Access Maced J Med Sci. 2018 Sep 23;6(9):1722-1726. doi: 10.3889/oamjms.2018.345. eCollection 2018 Sep 25.

PMID:
30337998
7.

AKT-targeted anti-inflammatory activity of Panax ginseng calyx ethanolic extract.

Han SY, Kim J, Kim E, Kim SH, Seo DB, Kim JH, Shin SS, Cho JY.

J Ginseng Res. 2018 Oct;42(4):496-503. doi: 10.1016/j.jgr.2017.06.003. Epub 2017 Jun 23.

PMID:
30337810
8.

Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.

Ezewudo M, Borens A, Chiner-Oms Á, Miotto P, Chindelevitch L, Starks AM, Hanna D, Liwski R, Zignol M, Gilpin C, Niemann S, Kohl TA, Warren RM, Crook D, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, McNerney R, Cirillo DM, Schito M, Rodwell TC, Posey J.

Sci Rep. 2018 Oct 18;8(1):15382. doi: 10.1038/s41598-018-33731-1.

PMID:
30337678
9.
10.

Tracking EBV-encoded RNAs (EBERs) from the nucleus to the excreted exosomes of B-lymphocytes.

Ahmed W, Tariq S, Khan G.

Sci Rep. 2018 Oct 18;8(1):15438. doi: 10.1038/s41598-018-33758-4.

PMID:
30337610
11.

Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.

Wang Q, Ma X, Zhang X, Ong JJ, Jing J, Zhang L, Wang LH.

Sex Transm Infect. 2018 Oct 18. pii: sextrans-2018-053636. doi: 10.1136/sextrans-2018-053636. [Epub ahead of print]

PMID:
30337414
12.

Treatment for Chronic Hepatitis C Prior to Total Hip Arthroplasty Significantly Reduces Periprosthetic Joint Infection.

Bedair HS, Schurko BM, Dwyer MK, Novikov D, Anoushiravani AA, Schwarzkopf R.

J Arthroplasty. 2018 Sep 19. pii: S0883-5403(18)30817-9. doi: 10.1016/j.arth.2018.09.036. [Epub ahead of print]

PMID:
30337253
13.

Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis.

López-Gatell H, García-García L, Echániz-Avilés G, Cruz-Hervert P, Olamendi-Portugal M, Castañeda-Desales D, Sanchez-Alemán MÁ, Romero-Martínez M, DeAntonio R, Cervantes-Apolinar MY, Cortes-Alcalá R, Alpuche-Aranda C.

Vaccine. 2018 Oct 15. pii: S0264-410X(18)31403-8. doi: 10.1016/j.vaccine.2018.10.037. [Epub ahead of print]

PMID:
30337174
14.

Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment.

Ji F, Yeo YH, He C, Li J, Gao X, Li Z, Henry L, Nguyen MH.

J Hepatol. 2018 Oct 15. pii: S0168-8278(18)32390-0. doi: 10.1016/j.jhep.2018.09.016. [Epub ahead of print] No abstract available.

PMID:
30337127
15.

Prognosis of cirrhotic patients admitted to Emergency Departments: A multicenter study.

Javaud N, Bonnin L, Lapostolle F, Boubaya M, Bardis A, Dufau R, Ghazali A, Reuter PG, Pateron D, Adnet F.

Am J Emerg Med. 2018 Oct 12. pii: S0735-6757(18)30822-2. doi: 10.1016/j.ajem.2018.10.008. [Epub ahead of print]

PMID:
30337088
16.

Tumor necrosis factor inhibitors and risk of peripheral neuropathy in patients with rheumatic diseases.

Etminan M, Sodhi M, Samii A, Carleton BC, Kezouh A, Antonio Avina-Zubieta J.

Semin Arthritis Rheum. 2018 Sep 27. pii: S0049-0172(18)30201-4. doi: 10.1016/j.semarthrit.2018.09.006. [Epub ahead of print]

PMID:
30337056
17.

Delivering the hepatitis C cure to Aboriginal people: documenting the perspectives of one Aboriginal Health Service.

Wallace J, Hanley B, Belfrage M, Gregson S, Quiery N, Lucke J.

Aust J Prim Health. 2018 Oct 19. doi: 10.1071/PY18024. [Epub ahead of print]

PMID:
30336799
18.

Using telehealth to improve access to hepatitis C treatment in the direct-acting antiviral therapy era.

Schulz TR, Kanhutu K, Sasadeusz J, Watkinson S, Biggs BA.

J Telemed Telecare. 2018 Oct 18:1357633X18806651. doi: 10.1177/1357633X18806651. [Epub ahead of print]

PMID:
30336724
19.

Managing HCV treatment failure and the potential of resistance testing in informing second line therapy options.

Loggi E, Vukotic R, Andreone P.

Expert Rev Anti Infect Ther. 2018 Oct 19. doi: 10.1080/14787210.2018.1538783. [Epub ahead of print]

PMID:
30336699
20.

Protective Effect of Bergenin against Cyclophosphamide-Induced Immunosuppression by Immunomodulatory Effect and Antioxidation in Balb/c Mice.

Qi Q, Dong Z, Sun Y, Li S, Zhao Z.

Molecules. 2018 Oct 17;23(10). pii: E2668. doi: 10.3390/molecules23102668.

PMID:
30336565

Supplemental Content

Loading ...
Support Center